when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Type 2 Diabetes · news · pharmadog

← back to Type 2 Diabetes

News mentioning Type 2 Diabetes

86 stories

Jul 27, 26AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failurebiospace

Jul 24, 26Roche cans one Carmot obesity asset as another shows best-in-class potentialbiospace

Jul 23, 26Lilly, with new data, to seek FDA approval of obesity drug retatrutidebiopharma dive

Jul 23, 26Lilly preps FDA run for ‘triple-G’ weight loss drug with Phase 3 databiospace

Jul 23, 26Lilly’s triple-G drug hits 22.6% weight loss, but impact on reducing cardio risk is less clearfiercebiotech

Jul 22, 26FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilotfda press

Jul 20, 26Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independencebiospace

Jul 9, 26Opinion: Who benefits from classifying obesity as a disease?stat

Jul 8, 26Another big premium hike on the horizonstat

Jul 8, 26Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefitsstat

Jun 12, 26FDA Clears First Over-the-Counter Continuous Glucose Monitor for Childrenfda press

Jun 9, 26Dexcom RCT suggests CGM benefits for broad diabetes populationstat

Jun 9, 26Alcohol study discarded by Trump officials is published in scientific journalstat

Jun 8, 26ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ optionbiopharma dive

Jun 4, 26Scientists uncover a new hiding spot for HIVstat

Jun 4, 26Male puberty is understudied — but when it starts may predict long-term health risksstat

Jun 3, 26Is the military fueling eating disorders?stat

Jun 3, 26Top ultra-processed food researchers call for sweeping policy change: ‘The system is rigged’stat

Jun 2, 26Eli Lilly issues data sharing ultimatum to 340B hospitalsbiopharma dive

May 18, 26STAT+: Maryland state affordability board places a price cap on Ozempicstat

May 12, 26Second Clinical Scenario - Progressive Disease Despite Hematocrit Controlonclive

May 11, 26Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trialbiopharma dive

Apr 30, 26STAT+: New obesity tool aims to predict risk of 18 serious complicationsstat

Apr 24, 26Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelicsbiopharma dive

Apr 23, 26Novo's pill for kids; Altimmune’s $225M offering; Merck teams with Google Cloudendpoints

Dec 22, 25Fierce Biotech Fundraising Tracker '26: TriGemX tacks on $94M; AnaCardio adds $71Mfiercebiotech

← prevpage 3 of 3next →